Mayo Clinic Laboratory and Pathology Research Roundup: April 2 - Insights
This week's research roundup feature: Follicular lymphoma (FL) is an indolent non-Hodgkin lymphoma of germinal center origin, which presents with significant biologic and clinical heterogeneity. Using RNA-seq on B cells sorted from 87 FL...
Sickle cell disease: How new technologies are transforming patient lives - Insights
In this “Future Direction of Laboratory Medicine” webinar, Maggie DiGuardo, M.D., and Justin Juskewitch, M.D., Ph.D., will review the current knowledge regarding sickle cell disease from its genetic cause to the myriads of effects it can...
Optimizing Cancer Care: ASCO Guidelines for Germline Genetic Testing - Insights
PACE / State of FL- Presentation Recording Coming Soon This webinar will delve into the latest ASCO guidelines for selection of germline genetic testing panels for cancer patients. Key topics include the importance of taking and recording a...
The Quality Auditor Role - Assessing the Laboratory - Insights
PACE/State of FL Internal assessments are integral to a laboratory’s quality management system (QMS). They allow laboratories to evaluate compliance with regulatory and accreditation requirements, and laboratory operational practices....
Metagenomic Sequencing - A Tool for Diagnosis of Central Nervous System Infection - Insights
PACE / State of FL This webinar will cover metagenomic sequencing for diagnosing central nervous system infection. Content will be shared regarding technical details, clinical applications, and results interpretation, drawing on both...
Understanding a Broken Heart: Genetic Testing After Sudden Cardiac Death - Insights
PACE/State of FLPresentation Recording Coming Soon Sudden cardiac death (SCD) is a devastating event that occurs unexpectedly, often without any prior symptoms. This webinar will discuss how postmortem genetic testing may be used in...
Facebook Email or phone Password...
LinkedIn Login, Sign in | LinkedIn
Login to LinkedIn to keep in touch with people you know, share ideas, and build your career.
As part of Mayo Clinic’s Neuro-Oncology practice, the Division of Laboratory Genetics and Genomics tests about 50 brain tumors a week, and upwards of 1,500 brain tumors a year from all over the world.
What Happens Next? Lab-Developed Test Rule Vacated: Bill Morice, M.D., Ph.D. - Insights
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to discuss the...